• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者自我报告药物安全量表(SR-PMSS)的编制与心理测量学评估。

Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS).

作者信息

Qin Ning, Duan Yinglong, Shi Shuangjiao, Li Xiao, Liu Haoqi, Zheng Feng, Zhong Zhuqing, Xiang Guliang

机构信息

Nursing Department, The Third Xiangya Hospital of Central South University, Changsha, China.

Department of Emergency, The Third Xiangya Hospital of Central South University, Changsha, China.

出版信息

Ther Adv Drug Saf. 2023 Mar 27;14:20420986231152934. doi: 10.1177/20420986231152934. eCollection 2023.

DOI:10.1177/20420986231152934
PMID:37007873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10052723/
Abstract

OBJECTIVES

Patient medication safety can affect their clinical outcomes and plays an important role in patient safety management. However, few tools have been developed to assess patient medication safety. This study aimed to develop and validate the self-reported patient medication safety scale (SR-PMSS).

METHODS

We developed SR-PMSS guided by the Donabedian Structure-Process-Outcome framework and used psychometric methods to test its validity and reliability.

RESULTS

A total of 501 patients with an average age of 56.81 ± 14.47 were enrolled in this study. The SR-PMSS consisted of 21 items and 5 factors. The content validity was good with item-level content validity index (CVI) > 0.78, average scale-level CVI (S-CVI) > 0.9, and universal agreement S-CVI > 0.8. Exploratory factor analysis extracted a five-factor solution with eigenvalues > 0.1, explaining 67.766% of the variance. Confirmatory factor analysis showed good model fit, acceptable convergent validity, and discriminant validity. The Cronbach's α coefficient for SR-PMSS was 0.929, the split-half reliability coefficient was 0.855, and the test-retest reliability coefficient was 0.978.

CONCLUSIONS

The SR-PMSS was a valid and reliable instrument with good reliability and validity to evaluate the level of patient medication safety. The target users of the SR-PMSS are all people who are taking or have used prescription medications. The SR-PMSS can be used by healthcare providers in clinical practice and research to identify patients at risk for medication use and intervene with them to reduce adverse medication events and provide support for patient safety management.

PLAIN LANGUAGE SUMMARY

  • Medication therapy was the most common and frequent treatment method to prevent and cure diseases. Medication safety issues may occur in the process of medication use. Patient medication safety can affect their clinical outcomes and plays an important role in patient safety management. However, there are few tools to assess patient medication safety currently, and most of them focused on medication safety related to hospitals or healthcare workers. We developed the self-reported patient medication safety scale (SR-PMSS) guided by the Donabedian Structure-Process-Outcome framework. Then, we conducted a two-round expert consultation, clarity verification, and item simplification to determine the final version of the scale. The SR-PMSS consisted of 21 items and 5 factors and it had good validity and reliability. The target users of the SR-PMSS are all people who are taking or have used prescription medications. Healthcare providers can use the SR-PMSS in clinical practice and research to identify patients at risk for medication use and intervene with them to reduce adverse medication events and provide support for patient safety management.
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c657/10052723/444a0dff1355/10.1177_20420986231152934-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c657/10052723/444a0dff1355/10.1177_20420986231152934-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c657/10052723/444a0dff1355/10.1177_20420986231152934-fig1.jpg
摘要

目的

患者用药安全会影响其临床结局,在患者安全管理中发挥着重要作用。然而,用于评估患者用药安全的工具却很少。本研究旨在开发并验证患者自我报告用药安全量表(SR-PMSS)。

方法

我们在唐纳贝迪安结构-过程-结果框架的指导下开发了SR-PMSS,并使用心理测量方法测试其有效性和可靠性。

结果

本研究共纳入501例患者,平均年龄为56.81±14.47岁。SR-PMSS由21个条目和5个因子组成。内容效度良好,条目水平的内容效度指数(CVI)>0.78,量表平均水平的CVI(S-CVI)>0.9,全体一致的S-CVI>0.8。探索性因子分析提取出一个特征值>0.1的五因子解,解释了67.766%的方差。验证性因子分析显示模型拟合良好,具有可接受的收敛效度和区分效度。SR-PMSS的Cronbach's α系数为0.929,分半信度系数为0.855,重测信度系数为0.978。

结论

SR-PMSS是一种有效且可靠的工具,具有良好的信效度,可用于评估患者用药安全水平。SR-PMSS的目标用户是所有正在服用或曾经使用过处方药的人。医疗服务提供者可在临床实践和研究中使用SR-PMSS来识别用药风险患者,并对他们进行干预,以减少用药不良事件,为患者安全管理提供支持。

通俗易懂的总结

  • 药物治疗是预防和治疗疾病最常见且频繁的治疗方法。用药过程中可能会出现用药安全问题。患者用药安全会影响其临床结局,在患者安全管理中发挥着重要作用。然而,目前很少有评估患者用药安全的工具,且大多数工具关注的是与医院或医护人员相关的用药安全。我们在唐纳贝迪安结构-过程-结果框架的指导下开发了患者自我报告用药安全量表(SR-PMSS)。然后,我们进行了两轮专家咨询、清晰度验证和条目简化,以确定量表的最终版本。SR-PMSS由21个条目和5个因子组成,具有良好的效度和信度。SR-PMSS的目标用户是所有正在服用或曾经使用过处方药的人。医疗服务提供者可在临床实践和研究中使用SR-PMSS来识别用药风险患者,并对他们进行干预,以减少用药不良事件,为患者安全管理提供支持。

相似文献

1
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS).患者自我报告药物安全量表(SR-PMSS)的编制与心理测量学评估。
Ther Adv Drug Saf. 2023 Mar 27;14:20420986231152934. doi: 10.1177/20420986231152934. eCollection 2023.
2
Psychometric properties and validation of the revised Chinese Medication Literacy Scale for Hypertensive Patients (C-MLSHP-R).高血压患者中文药物素养量表修订版(C-MLSHP-R)的心理测量学特性及效度验证
Front Cardiovasc Med. 2022 Sep 6;9:976691. doi: 10.3389/fcvm.2022.976691. eCollection 2022.
3
Cross-cultural adaptation and psychometric properties of the Chinese version of the postpartum depression literacy scale.产后抑郁知识量表中文版的跨文化适应及心理测量特性
Front Psychol. 2022 Aug 9;13:966770. doi: 10.3389/fpsyg.2022.966770. eCollection 2022.
4
The Development and Psychometric Assessment of Chinese Medication Literacy Scale for Hypertensive Patients (C-MLSHP).高血压患者中文用药素养量表(C-MLSHP)的编制与心理测量学评估
Front Pharmacol. 2020 Apr 30;11:490. doi: 10.3389/fphar.2020.00490. eCollection 2020.
5
Development and Preliminary Validation of the Chinese Version of the Totally Implantable Venous Access Port Self-Management Behavior Scale (CPTSMBS) for Patients with Cancer.癌症患者完全植入式静脉输液港自我管理行为量表中文版(CPTSMBS)的研制与初步验证
J Multidiscip Healthc. 2024 Aug 6;17:3803-3824. doi: 10.2147/JMDH.S467122. eCollection 2024.
6
The mothers' breastfeeding behaviour within six weeks postpartum: new scale development and psychometric validation study.产后 6 周内母亲的母乳喂养行为:新量表的开发和心理测量验证研究。
BMC Pregnancy Childbirth. 2023 Mar 2;23(1):138. doi: 10.1186/s12884-023-05439-2.
7
Development and validation of a new non-disease-specific survey tool to assess self-reported adherence to medication.一种用于评估自我报告的药物依从性的新型非疾病特异性调查工具的开发与验证。
Front Pharmacol. 2022 Dec 7;13:981368. doi: 10.3389/fphar.2022.981368. eCollection 2022.
8
Development and psychometric evaluation of a self-management behaviours scale in rheumatoid arthritis patients (RA-SMBS).类风湿关节炎患者自我管理行为量表(RA-SMBS)的编制及心理测量学评价
BMC Nurs. 2023 Feb 14;22(1):40. doi: 10.1186/s12912-023-01173-4.
9
Psychometric Measurements of the Adherence to Refills and Medication Scales Among Patients With HIV/AIDS in Indonesia.印度尼西亚 HIV/AIDS 患者对药物和药物补充剂量的依从性量表的心理计量学测量。
Value Health Reg Issues. 2024 Nov;44:101027. doi: 10.1016/j.vhri.2024.101027. Epub 2024 Aug 14.
10
Designing and psychometric evaluation of disease-related fear scale (D-RFS) in adults with epilepsy: A sequential exploratory mixed methods design.成人癫痫患者疾病相关恐惧量表(D-RFS)的设计和心理计量学评估:序贯探索性混合方法设计。
Epilepsy Behav. 2020 Sep;110:107169. doi: 10.1016/j.yebeh.2020.107169. Epub 2020 Jun 3.

引用本文的文献

1
Patient-centric decision-making in supplements intake and disclosure in clinical practice: a novel SIDP-12 tool to prevent drug-supplement interaction.临床实践中补充剂摄入与披露的以患者为中心的决策:一种预防药物-补充剂相互作用的新型SIDP-12工具
Ther Adv Drug Saf. 2024 Oct 30;15:20420986241294150. doi: 10.1177/20420986241294150. eCollection 2024.

本文引用的文献

1
Reliability and validity: Importance in Medical Research.信度和效度:医学研究中的重要性。
J Pak Med Assoc. 2021 Oct;71(10):2401-2406. doi: 10.47391/JPMA.06-861.
2
Implementing an emergency department pharmacy service and its effect on medication safety.实施急诊科药房服务及其对用药安全的影响。
Int J Pharm Pract. 2021 Aug 11;29(4):394-396. doi: 10.1093/ijpp/riab012.
3
Development and Validation of the Medication Safety Competence Scale for Nurses.护士用药安全能力量表的编制与验证
West J Nurs Res. 2021 Jul;43(7):686-697. doi: 10.1177/0193945920969929. Epub 2020 Nov 6.
4
Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission.全院用药核对计划:错误识别、成本效益及入院时高危个体的检测
Integr Pharm Res Pract. 2020 Oct 13;9:195-203. doi: 10.2147/IPRP.S269857. eCollection 2020.
5
Perceived Family Support and Medication Adherence amongst Hypertensive Outpatients in a Tertiary Hospital, Ibadan, Nigeria.尼日利亚伊巴丹一家三级医院高血压门诊患者的家庭支持认知与药物依从性
West Afr J Med. 2020 Oct;37(5):481-489.
6
Online Medication Information for Citizens: A Comparison of Demands on eHealth Literacy.公民在线用药信息:对电子健康素养需求的比较
Stud Health Technol Inform. 2020 Jun 16;270:1026-1030. doi: 10.3233/SHTI200317.
7
Economic analysis of the prevalence and clinical and economic burden of medication error in England.英格兰药物错误的流行情况及其临床和经济负担的经济分析。
BMJ Qual Saf. 2021 Feb;30(2):96-105. doi: 10.1136/bmjqs-2019-010206. Epub 2020 Jun 11.
8
Interventions to ensure medication safety in acute care: an umbrella review.干预措施以确保急性护理中的药物安全:伞式综述。
Int J Evid Based Healthc. 2020 Jun;18(2):188-211. doi: 10.1097/XEB.0000000000000232.
9
The Development and Psychometric Assessment of Chinese Medication Literacy Scale for Hypertensive Patients (C-MLSHP).高血压患者中文用药素养量表(C-MLSHP)的编制与心理测量学评估
Front Pharmacol. 2020 Apr 30;11:490. doi: 10.3389/fphar.2020.00490. eCollection 2020.
10
Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review.从医院出院到社区环境后药物错误和与药物相关的伤害的发生率和性质:系统评价。
Drug Saf. 2020 Jun;43(6):517-537. doi: 10.1007/s40264-020-00918-3.